Teva Pharmaceutical Industries Ltd. — Earnings Release 2005

Jul 19, 2005

C002	��� ������ ��������� ��"�		2
Public	TEVA- PHARMACEUTICAL INDUSTRIES LTD.
	2530	Corporation no: 520013954
	Stock Exchange/Market: ���
	310
	380	P.O.B 3190 , Petach Tikva 49131 , ,
	Tel: 03-9267297 , 03-9267281 Fax: 03-9267429
	E.mail address: DORIT@TEVA.CO.IL	Date of transmission: 19/07/2005
		Time of broadcast: 08:52 08:50:31
		Reference: 2005-02-055416

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on TEVA ANNOUNCES RECORD GLOBAL IN-MARKET COPAXONE� SALES OF $291 MILLION IN THE SECOND QUARTER, AN INCREASE OF 29%
CopaxoneQ205190705_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous name of reporting entity:
Date of revision of form structure: 11/07/2005
- - -
Name of the Signatory : Karniel Uzi , , Position of Signatory in the reporting corporation: General Counsel & Company Secretary
Basel Telephone: 03-9267297 , Facsimile: 03-9267429 , E-mail: uzi.karniel@teva.co.il